BioSpace News Archive

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces it has received more than 50,000 COVID-19 specimens to date for processing through its RT-PCR technology at its CLIA-certified, CAP-accredited high-complexity molecular laboratory.

Kits Sent to Educators and Families Provide 11,000 Additional Youth Access to the STEM Education Activities

ATCC, the world’s premier biological materials management and standards organization, today announced a potential 10-year, Indefinite Delivery/Indefinite Quantity (IDIQ) contract award with a ceiling value of $250 million from the Biomedical Advanced Research and Development Authority (BARDA),

Unchained Labs, the life sciences company that’s all about getting researchers the right tool for the job, launched its new gene therapy quantification application on Stunner

Aro Biotherapeutics announced that Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, has exercised an option to acquire a license to an undisclosed antisense oligonucleotide -Centyrin drug conjugate.

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving the measurement of pharmaceutical aerosols.

PRC Clinical has galvanized its brand and website to reflect its increasingly specialized, high-touch approach to early phase clinical research.

Molecular diagnostics company Lucence today announced the availability of the world’s first assay kit to directly profile SARS-CoV-2 subgenomic RNA (sgRNA), a marker of active viral replication1, from clinical samples.

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data presented during the Heart Failure Society of America’s Annual Scientific Meeting focused on the use of Daxor’s BVA-100® blood test for uniquely measuring anemia.

Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is pleased to release the CEO’s letter to the shareholders.